Microproteomics by liquid extraction surface analysis: Application to FFPE tissue to study the fimbria region of tubo-ovarian cancer

Proteomics - Clinical Applications

Volumn 7, Issue 3-4, 2013, Pages 234-240

  Wisztorski, Maxence ^a   Fatou, Benoit ^a   Franck, Julien ^a   Desmons, Annie ^a   Farré, Isabelle ^a,b   Leblanc, Eric ^a,b   Fournier, Isabelle ^a   Salzet, Michel ^a  

^a UNIV LILLE   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

Liquid extraction surface analysis; Microproteomics; Shotgun proteomics; Signaling pathway; Tubo ovarian cancer

Indexed keywords

BIOLOGICAL MARKER; EMERIN; FORMALDEHYDE; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEAR PROTEIN; PARAFFIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN HUWE1; PROTEIN MDM2; PROTEIN P53; RIBOSOMAL PROTEIN L5; RIBOSOME PROTEIN; TRYPSIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIGEN RETRIEVAL; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER TISSUE; FEMALE; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; HEAT STRESS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID EXTRACTION SURFACE ANALYSIS; LIQUID PHASE MICROEXTRACTION; MASS SPECTROMETRY; MICROPROTEOMICS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TISSUE FIXATION; TISSUE SECTION; TUBOOVARIAN CANCER;

FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; MASS SPECTROMETRY; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PROTEOME; PROTEOMICS; TISSUE FIXATION;

EID: 84876327507     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200070     Document Type: Article

References (29)

1. Projection de l'incidence et de la mortalité par cancer en France en 2011. Rapport technique. Saint-Maurice: Institut de veille sanitaire; 2011. 78 p.
2. Shih, I.-M., Kurman, R. J., Ovarian tumorigenesis. Am. J. Pathol. 2004, 164, 1511-1518.
3. Kurman, R. J., Shih, I.-M., The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 2010, 34, 433-443.
4. Lee, Y., Miron, A., Drapkin, R., Medeiros, F. et al., A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 2007, 211, 26-35.
5. Crum, C. P., McKeon, F. D., Xian, W., BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis. Int. J Gynecol. Cancer 2012, 22(Suppl 1), S29-S34.
6. Caprioli, R. M., Farmer, T. B., Gile, J., Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 1997, 69, 4751-4760.
7. Lemaire, R., Desmons, A., Tabet, J. C., Day, R. et al., Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections research articles. J. Proteome Res. 2007, 6, 1295-1305.
8. Quanico, J., Franck, J., Dauly, C., Strupat, K. et al., Development of liquid microjunction extraction strategy for improving protein identification from tissue sections. J Proteomics. 2013, 79C, 200-218.
9. Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A. et al., The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am. J. Surg. Pathol. 2006, 30, 230-236.
10. Cowley, M. J., Pinese, M., Kassahn, K. S., Waddell, N. et al., PINA v2.0: mining interactome modules. Nucleic Acids Res. 2012, 40, D862-D865.
11. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M. et al., The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39, D561-D568.
12. Qi, C.-F., Kim, Y.-S., Xiang, S., Abdullaev, Z. et al., Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. Int. J. Mol. Sci. 2012, 13, 6204-6219.
13. Persons, D. L., Yazlovitskaya, E. M., Pelling, J. C., Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 2000, 275, 35778-35785.
14. Zhang, Y., Wolf, G. W., Bhat, K., Jin, A. et al., Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 2003, 23, 8902-8912.
15. Guo, A., Salomoni, P., Luo, J., Shih, A. et al., The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2000, 2, 730-736.
16. Kurki, S., Latonen, L., Laiho, M., Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J. Cell Sci. 2003, 116(Pt 19), 3917-3925.
17. Bourguignon, L. Y. W., Peyrollier, K., Gilad, E., Brightman, A., Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J. Biol. Chem. 2007, 282, 1265-1280.
18. Cairo, S., De Falco, F., Pizzo, M., Salomoni, P. et al., PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. Oncogene 2005, 24, 2195-2203.
19. Adhikary, S., Marinoni, F., Hock, A., Hulleman, E. et al., The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005, 123, 409-421.
20. Wang, T.-H., Chao, A., Tsai, C.-L., Chang, C.-L. et al., Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol. Cell. Proteomics 2010, 9, 1873-1884.
21. Sillanpää, S., Anttila, M. A., Voutilainen, K., Sillanpa, S. et al., CD44 expression indicates favorable prognosis in epithelial ovarian cancer CD44 expression indicates favorable prognosis in epithelial ovarian cancer. 2003, 9, 5318-5324.
22. Ricciardelli, C., Sakko, A. J., Ween, M. P., Russell, D. L., Horsfall, D. J., The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 2009, 28, 233-245.
23. Capo-chichi, C. D., Cai, K. Q., Testa, J. R., Godwin, A. K., Xu, X.-X., Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol. Cell. Biol. 2009, 29, 4766-4777.
24. Huang, K.-C., Park, D. C., Ng, S.-K., Lee, J. Y. et al., Selenium binding protein 1 in ovarian cancer. Int. J. Cancer 2006, 118, 2433-2440.
25. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S. et al., Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 2001, 98, 15149-15154.
26. Jing, L., Liu, L., Yu, Y. P., Dhir, R. et al., Expression of myopodin induces suppression of tumor growth and metastasis. Am. J. Pathol. 2004, 164, 1799-1806.
27. Nash, M. A., Deavers, M. T., Freedman, R. S., The expression of decorin in human ovarian tumors. Clin. Cancer Res. 2002, 8, 1754-1760.
28. Heyman, L., Leroy-Dudal, J., Fernandes, J., Seyer, D. et al., Mesothelial vitronectin stimulates migration of ovarian cancer cells. Cell Biol. Int. 2010, 34, 493-502.
29. Waldemarson, S., Krogh, M., Alaiya, A., Kirik, U. et al., Protein expression changes in ovarian cancer during the transition from benign to malignant. J. Proteome Res. 2012, 11, 2876-2889.